Protocol Ledger

NCT07068074 · Phase III · RECRUITING

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Interventional Phase III clinical trial protocol NCT07068074 sponsored by ECOG-ACRIN Cancer Research Group in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-04-17 Enrollment: 428 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07068074
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)428 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07068074
Protocol FieldVerified Registry Value
NCT IdentifierNCT07068074
Consolidated Lead SponsorECOG-ACRIN Cancer Research Group
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment428 participants (ESTIMATED)
Registered Start Date2026-04-17
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI